SamSearch

    Closed Solicitation

    ADVANCED DEVELOPMENT OF MULTIVALENT VACCINE CANDIDATES FOR FILOVIRUS AND LASSA FEVER

    Federal procurement opportunity
    Sol. BAA-NIAID-NIHAI2016064Combined Synopsis/Solicitation
    Closed
    STATUS
    Closed
    closed Jul 15, 2016
    POSTED
    Jun 16, 2016
    Publication date
    NAICS CODE
    541715
    Primary industry classification
    PSC CODE
    —
    Product & service classification

    AI Summary

    This opportunity involves the advanced development of multivalent vaccine candidates targeting filoviruses, including Ebola, Sudan, and Marburg viruses, as well as Lassa Fever. Contracts will be awarded under a Broad Agency Announcement, focusing on innovative solutions in vaccine research and development.

    Contract details

    Solicitation No.
    BAA-NIAID-NIHAI2016064
    Notice Type
    Combined Synopsis/Solicitation
    Posted Date
    June 16, 2016
    Response Deadline
    July 15, 2016
    NAICS Code
    541715AI guide
    AI Product/Service
    both

    Description

    Contracts resulting from this Broad Agency Announcement will support the advanced development of multivalent vaccine candidates against filoviruses (Ebola virus, Sudan virus, and Marburg virus) and, optionally Lassa Fever.

    Key dates

    1. June 16, 2016Posted Date
    2. July 15, 2016Proposals / Responses Due

    AI search tags

    vaccine developmentbiotechnologypublic healthinfectious diseasefilovirus research

    Frequently asked questions

    ADVANCED DEVELOPMENT OF MULTIVALENT VACCINE CANDIDATES FOR FILOVIRUS AND LASSA FEVER is a federal acquisition solicitation. Review the full description, attachments, and submission requirements on SamSearch before the response deadline.

    SamSearch Platform

    Stop searching. Start winning.

    AI-powered intelligence for the right opportunities, the right leads, and the right time.

    Book a Demo